Related Experiment Video
Updated: Feb 25, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Atrial Fibrillation: Biomarkers Determining Prognosis
Savas Mazaris1, Gerasimos Siasos1,2, Evangelos Oikonomou1
1Department of Cardiology, 'Hippokration' General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
Biomarkers can improve risk assessment for atrial fibrillation (AF) patients, aiding clinicians in deciding on anticoagulant therapy. Incorporating these biological markers enhances existing risk scores for better patient management.
Area of Science:
- Cardiology
- Biomarker Research
Background:
- Atrial fibrillation (AF) increases thromboembolic and mortality risks, necessitating careful management.
- Current risk stratification scores like CHAD2DS2-VASc guide anticoagulant therapy decisions.
- Anticoagulant therapy presents both benefits and risks, requiring precise risk-benefit assessment.
Purpose of the Study:
- To review prognostic biomarkers in atrial fibrillation.
- To assess the potential of biomarkers in enhancing existing risk scores.
- To support clinical prognostication efforts in AF patients.
Main Methods:
- Literature review of studies on biomarkers in atrial fibrillation.
- Analysis of biomarkers associated with inflammation, fibrosis, hypercoagulability, and myocardial damage in AF.
- Evaluation of biomarker performance in risk stratification and prognostic assessment.
Main Results:
- Several biomarkers demonstrate prognostic potential in AF patients.
- Biomarkers offer insights into AF pathophysiology, including inflammation and myocardial damage.
- Incorporation of biomarkers may improve the accuracy of current risk scores.
Conclusions:
- Biomarkers are valuable tools for assessing prognosis in AF.
- Biomarker assessment can refine risk stratification beyond traditional scores.
- Further research into integrating biomarkers into clinical practice is warranted.
More Related Videos
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Dysrhythmias V: Evaluating Dysrhythmias
Acute Coronary Syndrome III: Diagnostic Studies